2003 NEWS RELEASES
December 18, 2003HUMAN GENOME SCIENCES ANNOUNCES LICENSE AGREEMENT WITH PFIZER
December 9, 2003HUMAN GENOME SCIENCES REPORTS INTERIM RESULTS OF PHASE 1 CLINICAL TRIALS OF LYMPHORADTM 131 AT 45TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY
December 8, 2003HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT HARRIS NESBITT GERARD CONFERENCE
December 5, 2003GENOMICS-DERIVED DRUG FOR CARDIOVASCULAR DISEASE TO ADVANCE TO PHASE 3 CLINICAL TRIALS
November 10, 2003HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT CREDIT SUISSE FIRST BOSTON CONFERENCE
November 6, 2003HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT CIBC WORLD MARKETS CONFERENCE
October 28, 2003HUMAN GENOME SCIENCES REPORTS THIRD QUARTER 2003 FINANCIAL RESULTS
October 28, 2003HUMAN GENOME SCIENCES REPORTS INTERIM RESULTS OF PHASE 1/2 CLINICAL TRIAL OF ALBUFERON IN PATIENTS INFECTED WITH HEPATITIS C VIRUS
October 28, 2003HUMAN GENOME SCIENCES REPORTS RESULTS OF PHASE 1 CLINICAL TRIAL OF LYMPHOSTAT-B IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
October 23, 2003HUMAN GENOME SCIENCES TO HOST CONFERENCE CALL TO DISCUSS THIRD QUARTER 2003 FINANCIAL RESULTS
September 25, 2003HUMAN GENOME SCIENCES INITIATES PHASE 2 CLINICAL TRIAL OF LYMPHOSTAT-B FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
September 25, 2003HUMAN GENOME SCIENCES REPORTS RESULTS OF CLINICAL TRIAL OF REPIFERMIN IN PATIENTS WITH CHRONIC VENOUS ULCERS
September 18, 2003HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT UBS WARBURG CONFERENCE
September 17, 2003HUMAN GENOME SCIENCES APPOINTS NEW MEMBERS TO ITS BOARD OF DIRECTORS
September 15, 2003HUMAN GENOME SCIENCES DESCRIBES ACTIVITY OF ABTHRAX AT 43RD ANNUAL INTERSCIENCE CONFERENCE ON ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
September 4, 2003HUMAN GENOME SCIENCES NAMES PERRY KARSEN SENIOR VICE PRESIDENT, BUSINESS DEVELOPMENT
September 4, 2003HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BEAR STEARNS CONFERENCE
September 2, 2003HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BIOCENTURY AND THOMSON FINANCIAL/CARSON CONFERENCE
August 19, 2003HUMAN GENOME SCIENCES RECEIVES FAST TRACK PRODUCT DESIGNATION FOR ABTHRAX FOR PREVENTION AND TREATMENT OF ANTHRAX INFECTIONS
August 7, 2003HUMAN GENOME SCIENCES ANNOUNCES LICENSE AGREEMENT WITH GENENTECH
July 29, 2003HUMAN GENOME SCIENCES REPORTS SECOND QUARTER 2003 FINANCIAL RESULTS
July 11, 2003HUMAN GENOME SCIENCES INITIATES CLINICAL DEVELOPMENT OF TRAIL RECEPTOR-2 ANTIBODY FOR TREATMENT OF CANCER
July 3, 2003HUMAN GENOME SCIENCES RESTRUCTURES REAL ESTATE FINANCINGS IN ACCORDANCE WITH NEW FASB GUIDANCE
June 25, 2003HUMAN GENOME SCIENCES UPDATES PROGRESS OF CLINICAL PROGRAMS AT BIO 2003
June 25, 2003HUMAN GENOME SCIENCES RECEIVES FDA CLEARANCE TO INITIATE HUMAN TRIAL OF NOVEL DRUG TO PREVENT AND TREAT ANTHRAX INFECTIONS
June 20, 2003HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BIO 2003 CONFERENCE
June 6, 2003HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT GOLDMAN SACHS CONFERENCE
June 2, 2003HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT NEEDHAM & COMPANY CONFERENCE
May 30, 2003HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT JMP SECURITIES CONFERENCE
May 12, 2003HUMAN GENOME SCIENCES ACQUIRES LICENSE FROM ABGENIX FOR HUMAN MONOCLONAL ANTIBODY TO KEY HIV/AIDS RECEPTOR
May 12, 2003HUMAN GENOME SCIENCES PROVIDES UPDATE OF COMPANY PROGRESS
May 9, 2003HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT ROBERT W. BAIRD CONFERENCE
May 5, 2003HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATIONS AT ANNUAL ANALYST & INVESTOR MEETING
April 30, 2003HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT MORGAN STANLEY CONFERENCE
April 28, 2003HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT CIBC WORLD MARKETS CONFERENCE
April 25, 2003HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCASTS OF PRESENTATIONS AT NASDAQ LIFE SCIENCES FORUM
April 24, 2003HUMAN GENOME SCIENCES REPORTS FINANCIAL RESULTS FOR FIRST QUARTER OF 2003
April 22, 2003HUMAN GENOME SCIENCES TO HOST CONFERENCE CALL TO DISCUSS FIRST QUARTER 2003 FINANCIAL RESULTS
April 21, 2003RESULTS OF PHASE 1 CLINICAL TRIAL DEMONSTRATE THAT LYMPHOSTAT-B IS SAFE AND BIOLOGICALLY ACTIVE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
April 2, 2003RESULTS OF PHASE 2 REPIFERMIN CLINICAL TRIAL DEMONSTRATE SAFETY AND EFFICACY IN PATIENTS WITH CANCER THERAPY-INDUCED MUCOSITIS
March 21, 2003HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BANC OF AMERICA HEALTH CARE CONFERENCE
March 18, 2003HUMAN GENOME SCIENCES DEVELOPS NEW MEANS TO PREVENT AND TREAT ANTHRAX INFECTIONS
March 14, 2003HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATIONS AT SG COWEN HEALTH CARE CONFERENCE
March 3, 2003HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT WACHOVIA SECURITIES CONFERENCE
February 28, 2003HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT LEHMAN BROTHERS GLOBAL HEALTHCARE CONFERENCE
February 27, 2003HUMAN GENOME SCIENCES RECEIVES MILESTONE PAYMENT FROM GLAXOSMITHKLINE FOR INITIATION OF CLINICAL TRIALS OF SECOND GENOMICS-DERIVED DRUG FOR CARDIOVASCULAR DISEASE
February 24, 2003HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BIO'S CEO & INVESTOR CONFERENCE
February 14, 2003HUMAN GENOME SCIENCES REPORTS FINANCIAL RESULTS FOR FULL YEAR AND FOURTH QUARTER 2002
February 13, 2003HUMAN GENOME SCIENCES DESIGNATED "EXCELLENT PLACE TO WORK" BY MARYLAND WORK-LIFE ALLIANCE
February 12, 2003HUMAN GENOME SCIENCES TO SPONSOR CONFERENCE CALL TO DISCUSS FULL YEAR AND FOURTH QUARTER 2002 FINANCIAL RESULTS
January 23, 2003HUMAN GENOME SCIENCES ESTABLISHES NEW SUBSIDIARY IN EUROPE
January 6, 2003HUMAN GENOME SCIENCES REPORTS PROGRESS IN CLINICAL TRIALS OF FIVE DRUGS AT JP MORGAN H&Q CONFERENCE
January 2, 2003HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT JPMORGAN H&Q HEALTHCARE CONFERENCE
